NASDAQ: LIXTLixte Biotechnology Holdings Inc Stock Ownership - Who owns Lixte Biotechnology Holdings?
Insider buying vs selling
Have Lixte Biotechnology Holdings Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when LIXT insiders and whales buy or sell their stock.
LIXT Shareholders
What type of owners hold Lixte Biotechnology Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| John S. Kovach | 12.44% | 1,540,183 | $10.60M | Insider |
| Glenn Krinsky | 11.91% | 1,474,998 | $10.15M | Insider |
| Gil Schwartzberg | 9.50% | 1,176,388 | $8.09M | Insider |
| Robert 1. Greenberg | 8.03% | 994,299 | $6.84M | Insider |
| Geordan Garrett Pursglove | 2.83% | 350,000 | $2.41M | Insider |
| Scotia Capital Inc | 2.29% | 283,162 | $1.95M | Institution |
| Philip F. Palmedo | 0.86% | 107,056 | $736.55k | Insider |
| Renaissance Technologies LLC | 0.75% | 93,000 | $639.84k | Institution |
| Stephen J. Forman | 0.60% | 74,804 | $514.65k | Insider |
| Federation Des Caisses Desjardins Du Quebec | 0.52% | 64,487 | $443.67k | Institution |
LIXT vs Biotech Stocks
Lixte Biotechnology Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.